Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TRPM2-IN-2 is a potent and selective TRPM2 inhibitor (IC50= 0.66 μM) with minimal activity against TRPM8 and TRPV1 (IC50> 10 μM). It demonstrates significant neuroprotective effects in both an in vitro oxygen-glucose deprivation/reperfusion (OGD/R) model and an in vivo transient middle cerebral artery occlusion (tMCAO) mouse model. TRPM2-IN-2 can be used for research related to ischemic stroke. |
| Targets & IC50 | TRPM2:0.66 μM |
| In vitro | TRPM2-IN-2 (LC4) demonstrates protective effects as an adamantane derivative in an OGD/R cell model, at concentrations ranging from 0.03 to 10 μM over 6 to 24 hours, and exhibits low cytotoxicity towards SH-SY5Y cells. At a concentration of 10 μM, TRPM2-IN-2 shows minimal inhibitory activity on TRPV1 and TRPM8, with inhibition rates of 20.5% and 23.2%, respectively. Additionally, it inhibits the hERG channel in CHO cells with an IC50 value of 21.61 μM. |
| In vivo | In a tMCAO mouse model, TRPM2-IN-2 administered intravenously at doses of 0.3, 1, and 3 mg/kg as a single dose demonstrated significant neuroprotective effects at 3 hours post-infusion. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.